PRESS-RELEASE ·Filed Jul 22, 2026
Press release: earnings
Actionable Insight • Neutral
Monitor the Q2 2026 earnings release on August 4, 2026 for product sales trends and any guidance revisions. This date announcement alone provides no trading catalyst.
Latest settled — T+20d ⚠ clustered
SUPN ▲ +0.55% at T+20d
NEUTRAL call ✓ call won +0.55% · α vs SPY -2.76% · entry $47.19 → $47.45
Latest observation: T+49 +0.94% FF3 residual α
T+1d
-2.10%
call -2.10% · α -2.20%
$46.20
settled 2mo ago
T+5d
-3.35%
call -3.35% · α -3.82%
$45.61
settled 2mo ago
T+20d
+0.55%
call +0.55% · α -2.76%
$47.45
settled 6w ago
T+60d
—
call — · α —
—
in 13d
Price Chart
Loading chart...
Executive Summary
Supernus Pharmaceuticals issued a press release announcing the date of its Q2 2026 earnings release and conference call, scheduled for August 4, 2026. No financial results, guidance, or material business updates were included — this is a routine administrative notification.
Key Facts
- Supernus Pharmaceuticals will report Q2 2026 financial results after market close on Tuesday, August 4, 2026.
- Management will host a conference call and webcast at 4:30 p.m. ET on August 4, 2026 to discuss results.
- No financial results, guidance updates, or material business developments are included in this press release.
Financial Impact
None — no financial data disclosed in this filing.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3331778 |
20 reports for SUPN
75% Hit rate best @ T+1▲ +8.46%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 20d ago | DEFM14A | $41.49 $42.78 | ▲ +3.11% | ▲ +3.00% | $42.60 (+2.68%) |
Aug 3, 2026 8w ago | DEFA14A / 425 | $43.25 $46.88 | ▲ +8.39% | ▲ +8.49% | $42.60 (−1.50%) |
Aug 3, 2026 8w ago | 8-K | $43.25 $46.88 | ▲ +8.39% | ▲ +8.49% | $42.60 (−1.50%) |
Aug 3, 2026 8w ago | DEFA14A / 425 | $46.00 $47.07 | ▲ +2.33% | ▲ +0.30% | $42.60 (−7.39%) |
Aug 3, 2026 8w ago | 8-K | $46.00 $47.07 | ▲ +2.33% | ▲ +0.30% | $42.60 (−7.39%) |
Aug 3, 2026 8w ago | 8-K | $46.00 $47.07 | ▲ +2.33% | ▲ +0.30% | $42.60 (−7.39%) |
Aug 3, 2026 8w ago | DEFA14A / 425 / 8-K | $46.00 $47.07 | ▲ +2.33% | ▲ +0.30% | $42.60 (−7.39%) |
Jul 22, 2026 10w ago | 8-K | $47.19 $45.61 | ▼ −3.35% | ▼ −3.82% | $42.60 (−9.73%) |
Jul 22, 2026 10w ago | Press Release | $47.19 $45.61 | ▼ −3.35% | ▼ −3.82% | $42.60 (−9.73%) |
Jul 20, 2026 10w ago | Court Ruling | $47.42 $46.20 | ▼ −2.57% | ▼ −2.15% | $42.60 (−10.16%) |
Showing 10 of 20
US Market Status
Market Open — Closes in 51m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access